ProfileGDS4718 / 1564277_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 64% 55% 65% 67% 62% 64% 64% 62% 64% 64% 66% 64% 62% 64% 58% 63% 63% 62% 63% 67% 66% 60% 59% 65% 62% 63% 61% 57% 67% 66% 62% 64% 64% 63% 64% 66% 65% 64% 62% 63% 66% 61% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3261263
GSM549102patient 115, normal, homogenized [OPG study]6.4231264
GSM549104patient 119, normal, homogenized [OPG study]5.8400355
GSM549108patient 138, normal, homogenized [OPG study]6.4882365
GSM549119patient 077, normal, homogenized [OPG study]6.5785467
GSM549133patient 032, cancer, homogenized [OPG study]6.2525462
GSM549139patient 042, cancer, homogenized [OPG study]6.4151764
GSM549099patient 107, normal, homogenized [OPG study]6.3807164
GSM549109patient 139, normal, homogenized [OPG study]6.2446362
GSM549110patient 046, normal, homogenized [OPG study]6.3705464
GSM549114patient 063, normal, homogenized [OPG study]6.3498464
GSM549122patient 082, normal, homogenized [OPG study]6.5835966
GSM549134patient 033, cancer, homogenized [OPG study]6.3572864
GSM549136patient 036, cancer, homogenized [OPG study]6.2317462
GSM549140patient 044, cancer, homogenized [OPG study]6.4134864
GSM549111patient 047, normal, homogenized [OPG study]5.9930358
GSM549113patient 057, normal, homogenized [OPG study]6.3202763
GSM549132patient 031, cancer, homogenized [OPG study]6.3305463
GSM549137patient 038, cancer, homogenized [OPG study]6.2629962
GSM549142patient 047, cancer, homogenized [OPG study]6.3724463
GSM549100patient 110, normal, homogenized [OPG study]6.5978467
GSM549107patient 135, normal, homogenized [OPG study]6.5310466
GSM549115patient 068, normal, homogenized [OPG study]6.1376660
GSM549116patient 072, normal, homogenized [OPG study]6.0704259
GSM549120patient 078, normal, homogenized [OPG study]6.485365
GSM549131patient 030, cancer, homogenized [OPG study]6.2312662
GSM549118patient 074, normal, homogenized [OPG study]6.3106363
GSM549129patient 027, cancer, homogenized [OPG study]6.2276361
GSM549123patient 088, normal, homogenized [OPG study]5.9498657
GSM549124patient 006, cancer, homogenized [OPG study]6.6342167
GSM549126patient 015, cancer, homogenized [OPG study]6.5652766
GSM549128patient 025, cancer, homogenized [OPG study]6.2838162
GSM549103patient 117, normal, homogenized [OPG study]6.4109464
GSM549117patient 073, normal, homogenized [OPG study]6.3458164
GSM549138patient 041, cancer, homogenized [OPG study]6.3419963
GSM549141patient 045, cancer, homogenized [OPG study]6.4300864
GSM549130patient 028, cancer, homogenized [OPG study]6.5333166
GSM549101patient 111, normal, homogenized [OPG study]6.4745865
GSM549105patient 128, normal, homogenized [OPG study]6.422164
GSM549106patient 134, normal, homogenized [OPG study]6.2220962
GSM549112patient 048, normal, homogenized [OPG study]6.3581663
GSM549125patient 011, cancer, homogenized [OPG study]6.5698666
GSM549127patient 024, cancer, homogenized [OPG study]6.2559961
GSM549135patient 035, cancer, homogenized [OPG study]6.3519163